,,hummm.........I have always held the perspective that we and others are trying to get an epigenetic drug to markt here...any one will do,,,,in fact any one involved in this area of science,,,even a competitor,,!!,,,I feel that the proof will be in the pudding from any sucess, which will give value to all research companies involved in this field,,,especially our beloved 208. The field we are in is cutting edge so pessimisim surrounds us and all doing this research.

And as far as our stagnated share price,,sideliners are probably taking no risk with the high possibility of an ugly dilution come August. jmo